2367.HK HKSE
Giant Biogene Holding Co., Ltd.
1W: -5.1%
1M: -9.6%
3M: -10.9%
YTD: -31.9%
1Y: -60.5%
3Y: -31.8%
HK$23.44 ($2.99)
-1.02 (-4.17%)
Weekly Expected Move ±4.9%
HK$21
HK$22
HK$23
HK$25
HK$26
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market CapHK$24.9B ($3.2B)
52W Range22.86-56.25
Volume1,324,551
Avg Volume4,495,415
Beta0.73
DividendHK$2.70
Analyst Ratings
No analyst coverage
Company Info
CEOJianya Yan
Employees2,319
SectorConsumer Defensive
IndustryHousehold & Personal Products
IPO Date2022-11-04
Websitexajuzi.com
No. 1855, Shanglin Yuan
Xiâan, SA
CN
Xiâan, SA
CN
86 29 8115 6502
About Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Latest News
No recent news
Recent Insider Trades
No insider trades found